NMIBC
Clinical trials for NMIBC explained in plain language.
Never miss a new study
Get alerted when new NMIBC trials appear
Sign up with your email to follow new studies for NMIBC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for bladder cancer patients: experimental BCG treatment made available
Disease control AVAILABLEThis expanded access program offers a modified tuberculosis vaccine (recombinant BCG) to people with non-muscle invasive bladder cancer who cannot join a clinical trial. The treatment is given directly into the bladder and aims to control the disease. It is only for patients who …
Matched conditions: NMIBC
Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New bladder cancer drug gets first human test
Disease control Recruiting nowThis early-stage trial is testing a new drug called belzupacap sarotalocan (AU-011) for people with non-muscle-invasive bladder cancer. The drug is injected directly into the tumor, sometimes with a laser. The main goal is to see if this approach is safe and feasible. About 55 pa…
Matched conditions: NMIBC
Phase: PHASE1 • Sponsor: Aura Biosciences • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Engineered TB bacteria could offer new hope for bladder cancer patients
Disease control Recruiting nowThis early-stage trial is testing a new version of the BCG therapy, made from a genetically modified bacterium, for people with non-muscle invasive bladder cancer (NMIBC) who have not received BCG before. The treatment is given directly into the bladder through a catheter. The st…
Matched conditions: NMIBC
Phase: PHASE1, PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC